Abstract
The rejection of emerging contaminates, which are associated with potential adverse human-health effects, such as endocrine-disrupting compounds, emerging disinfection by-products, pharmaceutical residues, personal care products, and organic compounds, have increase the interest for membranes applications.
Previous reports using a membrane as a filter have contributed to an improved understanding of rejection mechanisms for emerging contaminates; for example, microfiltration, ultrafiltration, nanofiltration, and reverse osmosis have been investigated.
In this chapter, they are going to find an information about the role of membrane on emerging contaminant removal and, likewise, characteristics of emerging contaminants, membrane classification, sources and levels of drugs in wastewater, and removal of emerging contaminants using membranes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Petrovic M, de Alda MJL, Diaz-Cruz S, Postigo C, Radjenovic J, Gros M et al (2009) Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration. Philos Trans R Soc A 367(1904):3979–4003
Drewes JE, Bellona C, Oedekoven M, Xu P, Kim TU, Amy G (2005) Rejection of wastewater-derived micropollutants in high-pressure membrane applications leading to indirect potable reuse. Environ Prog 24(4):400–409
Petrović M, Gonzalez S, Barceló D (2003) Analysis and removal of emerging contaminants in wastewater and drinking water. Trends Anal Chem 22(10):685–696
Acero JL, Benitez FJ, Teva F, Leal AI (2010) Retention of emerging micropollutants from UP water and a municipal secondary effluent by ultrafiltration and nanofiltration. Chem Eng J 163(3):264–272. https://doi.org/10.1016/j.cej.2010.07.060
Halling-Sorensen B, Halling-Sorensen B, Nielsen SN, Nielsen SN, Lanzky PF, Lanzky PF et al (1998) Occurrence, fate and effects of pharmaceuticals substance in the environment – a review. Chemosphere 36(2):357–393
Garric J, Ferrari B (2005) Les substances pharmaceutiques dans les milieux aquatiques. Niveaux d’exposition et effet biologique : que savons nous? Rev des Sci l’eau 18(3):307. http://id.erudit.org/iderudit/705561ar
Lapworth DJ, Baran N, Stuart ME, Ward RS (2012) Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ Pollut 163:287–303. https://doi.org/10.1016/j.envpol.2011.12.034
Kaushik N (2008) Membrane separation Process. Prentice Hall, New Delhi
Seman MNA, Khayet M, Hilal N (2010) Nanofiltration thin-film composite polyester polyethersulfone-based membranes prepared by interfacial polymerization. J Membr Sci 348(1–2):109–116
Xu P, Drewes JE, Bellona C, Amy G, Kim T-U, Adam M et al (2005) Rejection of emerging organic micropollutants in nanofiltration-reverse osmosis membrane applications. Water Environ Res 77(1):40–48. http://www.jstor.org/stable/25045836
Diagne F, Malaisamy R, Boddie V, Holbrook RD, Eribo B, Jones KL (2012) Polyelectrolyte and silver nanoparticle modification of microfiltration membranes to mitigate organic and bacterial fouling. Environ Sci Technol 46(7):4025–4033
Radjenović J, Petrović M, Ventura F, Barceló D (2008) Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res 42(14):3601–3610
Robinson M, Kinna A, Scholfield D, Melinek B (2005) Minnesota Rural Water Association, 30/09/2017. [Online]. Available: www.mrwa.com/WaterWorksMnl/Chapter 19 Membrane Filtration
Acero JL, Javier Benitez F, Real FJ, Teva F (2012) Coupling of adsorption, coagulation, and ultrafiltration processes for the removal of emerging contaminants in a secondary effluent. Chem Eng J 210:1–8. https://doi.org/10.1016/j.cej.2012.08.043
Mohammad AW, Teow YH, Ang WL, Chung YT, Oatley-Radcliffe DL, Hilal N (2015) Nanofiltration membranes review: recent advances and future prospects. Desalination 356:226–254. https://doi.org/10.1016/j.desal.2014.10.043
Yoon Y, Westerhoff P, Snyder SA, Wert EC (2006) Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J Membr Sci 270(1–2):88–100
Bolong N, Ismail AF, Salim MR, Matsuura T (2009) A review of the effects of emerging contaminants in wastewater and options for their removal. Desalination 238(1–3):229–246. https://doi.org/10.1016/j.desal.2008.03.020
Verlicchi P, Galletti A, Petrovic M, BarcelÓ D (2010) Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J Hydrol 389(3–4):416–428. https://doi.org/10.1016/j.jhydrol.2010.06.005
Pauwels B, Fru Ngwa F, Deconinck S, Verstraete W (2006) Effluent quality of a conventional activated sludge and a membrane bioreactor system treating hospital wastewater. Environ Technol 27(4):395–402
Tam LS, Tang TW, Lau GN, Sharma KR, Chen GH (2007) A pilot study for wastewater reclamation and reuse with MBR/RO and MF/RO systems. Desalination 202(1–3):106–113
Dialynas E, Diamadopoulos E (2009) Integration of a membrane bioreactor coupled with reverse osmosis for advanced treatment of municipal wastewater. Desalination 238(1–3):302–311
Dolar D, Gros M, Rodriguez-Mozaz S, Moreno J, Comas J, Rodriguez-Roda I et al (2012) Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR-RO. J Hazard Mater 239–240:64–69. https://doi.org/10.1016/j.jhazmat.2012.03.029
Focazio MJ, Kolpin DW, Barnes KK, Furlong ET, Meyer MT, Zaugg SD et al (2008) A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States – (I) groundwater. Sci Total Environ 402(2–3):201–216
Terzić S, Senta I, Ahel M, Gros M, Petrović M, Barcelo D et al (2008) Occurrence and fate of emerging wastewater contaminants in Western Balkan Region. Sci Total Environ 399(1–3):66–77
Loos R, Gawlik BM, Locoro G, Rimaviciute E, Contini S, Bidoglio G (2009) EU-wide survey of polar organic persistent pollutants in European river waters. Environ Pollut 157(2):561–568
Carballa M, Omil F, Lema JM, Llompart M, García-Jares C, Rodríguez I et al (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38(12):2918–2926
Moon HB, Yoon SP, Jung RH, Choi M (2008) Wastewater treatment plants (WWTPs) as a source of sediment contamination by toxic organic pollutants and fecal sterols in a semi-enclosed bay in Korea. Chemosphere 73(6):880–889
Al-Odaini NA, Zakaria MP, Yaziz MI, Surif S (2010) Multi-residue analytical method for human pharmaceuticals and synthetic hormones in river water and sewage effluents by solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A 1217(44):6791–6806. https://doi.org/10.1016/j.chroma.2010.08.033
Arnot TC, Zahir N (1996) Membrane bioreactors as an alternative to conventional waste water treatment processes. Resour Environ Biotechnol 1(2):145–162
Chiemchaisri C, Yamamoto K (1994) Performance of membrane separation bioreactor at various temperatures for domestic wastewater treatment. J Membr Sci 87(1–2):119–129
Rosenberger S, Kraume M (2003) Filterability of activated sludge in membrane bioreactors. Desalination 151(2):195–200
Quintana JB, Weiss S, Reemtsma T (2005) Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 39(12):2654–2664
Joss A, Keller E, Alder AC, Göbel A, McArdell CS, Ternes T et al (2005) Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39(14):3139–3152
Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H (2005) Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 39(19):4797–4807
Kimura K, Amy G, Drewes J, Watanabe Y (2003) Adsorption of hydrophobic compounds onto NF/RO membranes: an artifact leading to overestimation of rejection. J Membr Sci 221(1–2):89–101
Kimura K, Amy G, Drewes JE, Heberer T, Kim TU, Watanabe Y (2003) Rejection of organic micropollutants (disinfection by-products, endocrine disrupting compounds, and pharmaceutically active compounds) by NF/RO membranes. J Membr Sci 227(1–2):113–121
Kimura K, Toshima S, Amy G, Watanabe Y (2004) Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes. J Membr Sci 245(1–2):71–78
Nghiem LD, Manis A, Soldenhoff K, Schäfer AI (2004) Estrogenic hormone removal from wastewater using NF/RO membranes. J Membr Sci 242(1–2):37–45
Stephenson T, Judd S, Jefferson B, Brindle K (2006) Membrane bioreactors for wastewater treatment. IWA Publishing, London, p 175
Clara M, Kreuzinger N, Strenn B, Gans O, Kroiss H (2005) The solids retention time – a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 39(1):97–106
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Gómez-Espinosa, R.M., Arizmendi-Cotero, D. (2017). Role of Membrane on Emerging Contaminant Removal. In: Gómez-Oliván, L. (eds) Ecopharmacovigilance. The Handbook of Environmental Chemistry, vol 66. Springer, Cham. https://doi.org/10.1007/698_2017_149
Download citation
DOI: https://doi.org/10.1007/698_2017_149
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73475-0
Online ISBN: 978-3-319-73476-7
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)